|
NUDCD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.860660E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.235800E-04 |
| Normal-vs-Stage2 |
9.456100E-02 |
| Normal-vs-Stage3 |
6.806800E-04 |
| Normal-vs-Stage4 |
1.442210E-01 |
| Stage1-vs-Stage2 |
6.336800E-01 |
| Stage1-vs-Stage3 |
2.364000E-01 |
| Stage1-vs-Stage4 |
3.731800E-01 |
| Stage2-vs-Stage3 |
2.378600E-01 |
| Stage2-vs-Stage4 |
7.988200E-01 |
| Stage3-vs-Stage4 |
1.087600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.917600E-03 |
| Normal-vs-AfricanAmerican |
2.04979999999244E-05 |
| Normal-vs-Asian |
9.005600E-01 |
| Caucasian-vs-AfricanAmerican |
1.387790E-02 |
| Caucasian-vs-Asian |
2.532800E-01 |
| AfricanAmerican-vs-Asian |
1.918800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.361400E-03 |
| Normal-vs-Female |
5.257800E-03 |
| Male-vs-Female |
8.679600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.216400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.010460E-02 |
| Normal-vs-Age(61-80Yrs) |
2.481500E-03 |
| Normal-vs-Age(81-100Yrs) |
1.661670E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.127800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.570200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.529600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.014400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.513600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.415400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.655800E-01 |
| Normal-vs-Grade 2 |
5.710200E-02 |
| Normal-vs-Grade 3 |
1.69562999999817E-05 |
| Normal-vs-Grade 4 |
9.532100E-02 |
| Grade 1-vs-Grade 2 |
6.738000E-01 |
| Grade 1-vs-Grade 3 |
2.026300E-02 |
| Grade 1-vs-Grade 4 |
4.996800E-01 |
| Grade 2-vs-Grade 3 |
2.203000E-03 |
| Grade 2-vs-Grade 4 |
8.076400E-01 |
| Grade 3-vs-Grade 4 |
1.801950E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.379900E-02 |
| Normal-vs-ccB subtype |
3.700400E-03 |
| ccA subtype-vs-ccB subtype |
1.953640E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.576400E-03 |
| Normal-vs-N1 |
4.336000E-01 |
| N0-vs-N1 |
5.189200E-01 |
|
|
